Cite
HARVARD Citation
Gilbert, D. et al. (2017). Quality‐of‐life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone‐releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer. BJU international. pp. 667-675. [Online].